KBC Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

KBC Group’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,621	Closed	-$30K	–	1514
2019 Q4	$30K	Hold	7,621	–	–	﹤0.01%	1442
2019 Q3	$37K	Hold	7,621	–	–	﹤0.01%	1401
2019 Q2	$46K	Buy	+7,621	New	+$40.5K	﹤0.01%	1359

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

KBC Group's DPLO Position: Q1 2020 in Review

KBC Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 7,621 shares — an estimated $30K sold.

KBC Group first reported a position in DPLO in Q2 2019 and held it in 3 quarters. The position peaked at $46K in Q2 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

KBC Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
KBC Group sold 7,621 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $30K.
KBC Group first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2019 and held it in 3 quarters.
KBC Group's DIPLOMAT PHARMACY, INC. position peaked at $46K in Q2 2019.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on KBC Group's 13F filing for Q1 2020, filed 4 May 2020.